The aim of palliative care is to maintain as high a quality of life (QoL) as possible despite a
life-threatening illness. Thus, the prescribed medications need to be evaluated and the …

Purpose Palliative cancer patients can benefit from deprescribing of potentially
inappropriate medications (PIMs). Tools and guidelines developed for the geriatric …

Purpose The transition from active cancer treatment to palliative care often results in a shift
in drug risk-benefit assessment which requires the deprescribing of various medications …

In palliative care, drugs are considered futile if they do not have a short-term benefit in
symptom control or quality of life. The authors examined pharmacotherapy prescribed for …

Purpose Current data suggests that potentially inappropriate medicines (PIMs) are common
in palliative cancer patients; however, there is a lack of criteria to assist clinicians in …

Abstract “Is my older cancer patient on too many medications?” is a question that confronts
many physicians. Increasing age is associated with an increase in comorbidity, and …

Patients with advanced illness such as cancer, chronic obstructive pulmonary disease, and
Parkinson's disease experience acute symptoms and are usually prescribed medications to …

Objectives Cancer patients who have transitioned from curative intent chemotherapy or
radiotherapy to palliative therapy have limited life expectancies. Due to this, medications for …

(1) Background: A pharmacist-led deprescribing service previously developed within the
Consultation-Based Palliative Care Team (CB-PCT) was implemented for terminal cancer …

Background Terminally ill cancer patients with limited life expectancies (LLEs) are often
prescribed multiple medications to control acute symptoms associated with cancer such as …